Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stem Cell Educator Therapy
- Development stage
- Phase 1
- Lead developer
- Throne Biotechnologies
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Extracorporeal, Intravenous
01
Overview
Stem Cell Educator Therapy is an ex vivo cell-based immune modulation treatment developed by Throne Biotechnologies in collaboration with Hackensack Meridian Health. The therapy is primarily designed to treat type 1 diabetes mellitus (T1D) by addressing the underlying autoimmune destruction of pancreatic islet beta cells. The procedure involves an extracorporeal circuit where a patient's blood is circulated through a closed-loop medical device containing adherent cord blood-derived multipotent stem cells (CB-SCs). During this brief contact, the patient's immune cells, including T lymphocytes and platelets, are "educated" by the CB-SCs to restore immune balance and induce tolerance. These re-educated cells are then returned to the patient's circulation, where they aim to suppress the autoimmune attack and promote the regeneration of islet function. This approach seeks to provide systemic immune modulation without the need for long-term immunosuppression. The therapy has received the FDA's Regenerative Medicine Advanced Therapy (RMAT) designation.
- Brand names
- Stem Cell Educator therapyStem Cell Educator® therapy
- Other names
- Stem Cell EducatorCB-SC therapy
Beyond the preview
Go deeper on Stem Cell Educator Therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stem Cell Educator Therapy.